StockWatch
·
Biotechnology: Biological Products (No Diagnostic Substances)
Corporate ActionMay 22, 2026, 04:08 PM

Curis Increases Authorized Capital Stock to 572.5M Shares

AI Summary

Curis, Inc. held its Annual Meeting of Stockholders on May 19, 2026, where shareholders approved an amendment to the Company's Restated Certificate of Incorporation. This amendment significantly increases the number of authorized shares of capital stock from 288,757,150 to 572,514,300 and common stock from 283,757,150 to 567,514,300. Additionally, the Company filed a Certificate of Elimination to remove the designations for Series A and Series B Convertible Preferred Stock, returning these shares to authorized and unissued preferred stock status. Stockholders also elected two Class III directors, approved executive compensation, and ratified PricewaterhouseCoopers LLP as the independent auditor.

Key Highlights

  • Stockholders approved an amendment to increase authorized capital stock from 288,757,150 to 572,514,300 shares.
  • Authorized common stock increased from 283,757,150 to 567,514,300 shares.
  • Certificate of Elimination filed to remove Series A and Series B Preferred Stock designations.
  • Martyn D. Greenacre and Kenneth I. Kaitin, Ph.D. were elected as Class III directors.
  • Nonbinding advisory proposal on executive compensation was approved with 16,379,076 votes For.
  • PricewaterhouseCoopers LLP was ratified as the independent auditor for 2026 with 23,513,646 votes For.
  • The amendment to increase authorized common stock was adopted with 21,649,122 votes For.